Enokizumab

DB05555InvestigationalProtein Based Therapies

A humanized immunoglobulin G1k anti-interleukin-9 mAb.

Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in asthma.Curator reviewed
Also known as
7F3com-2H2 · 7F3com2H2
Code names
MEDI-528

Resolves to

Compound
UNIII4BE5F78HRCAS909875-08-7
Targets
P15248IL9

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
382Drug interactionsStructured to mechanism, not free text
Sign in
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Enokizumab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In